@prefix orcid: .
@prefix this: .
@prefix sub: .
@prefix np: .
@prefix rdf: .
@prefix xsd: .
@prefix rdfs: .
@prefix ns2: .
@prefix ns1: .
@prefix prov: .
@prefix ns3: .
@prefix npx: .
sub:Head {
this: np:hasAssertion sub:assertion;
np:hasProvenance sub:provenance;
np:hasPublicationInfo sub:pubInfo;
a np:Nanopublication .
}
sub:assertion {
sub:assertion prov:wasGeneratedBy "S&T TWOC project version 1" .
sub:version prov:value "1"^^xsd:integer .
rdf:object ns1:C0011008 "date";
ns1:C1547350 "date";
ns1:C1548309 "date";
ns1:C2348077 "date";
ns1:C2740799 "date" .
rdf:predicate ns3:TRIPLE_UID:wu0iwj8x-TRIPLE-ABSTRACT-1 "show" .
rdf:subject ns1:C0011777 "dexamethasone";
ns1:C4726677 "remdesivir" .
rdfs:Triple-UID ns2:TRIPLE_UID:wu0iwj8x-TRIPLE-ABSTRACT-1 "wu0iwj8x-TRIPLE-ABSTRACT-1" .
rdfs:sentence rdfs:label "To date, only dexamethasone and remdesivir have been shown to be effective, but several other promising candidates are in trials." .
rdfs:triple rdfs:label "only dexamethasone and remdesivir shown To date" .
}
sub:provenance {
sub:assertion prov:generatedAtTime "2021-07-25T21:45:36.473448"^^xsd:dateTime .
}
sub:pubInfo {
sub:sig npx:hasAlgorithm "RSA";
npx:hasPublicKey "MIGfMA0GCSqGSIb3DQEBAQUAA4GNADCBiQKBgQCSLeezU8JYlBsrgXOGXX4fxOq4oydsMzMK1CN0Rez2OEd2IYk18R4DetcZXwGhN3Pil7qcgNkiGvTirJXIo8zHl7jVehs19EdYtrttCKEaXRzWIr4LuCrfGedkvonEMWqR8e1GdQsLgEEyM50BD6Qw+srQt9ozcqf/9wG2MAMX9QIDAQAB";
npx:hasSignature "eGAhO/ykxft4Dtjp3WgFhq5Qb3o/cO524fiAoI/t4Qn+tDgI13AZX3ObT7C4tt2OmcnQXUA6CBU4xqnF3A6iegVeVWhb0Dso1hvVPVaOK1ueGkakToUQKqqje1JTNCfUI9w0/BxelibvyKKGdSRPWb0zfxze+gZUnSMsvg1kXNI=";
npx:hasSignatureTarget this: .
this: prov:generatedAtTime "2021-07-25T21:45:36.473448"^^xsd:dateTime;
prov:wasAttributedTo orcid:0000-0002-8954-0470 .
}